Login / Signup

Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent β-Thalassaemia: A Single-Center Experience.

Weijian ZhuYing HeMufang HuangShezhu FuZiyi LiuXiaoqi WangZhixin LiXiaoliang LiJiangming ChenYangqiu Li
Published in: International journal of general medicine (2024)
Thalidomide was well tolerated in the long term, while it significantly improved Hb levels and reduced the transfusion burden.
Keyphrases
  • patients undergoing
  • cardiac surgery
  • sickle cell disease
  • acute kidney injury
  • risk factors